Loading, please wait ...

News Analytics

ACADIA Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company focused largely on the marketing of Nuplazid (pimavanserin), to treat hallucinations and delusions associated with Parkinson's disease psychosis, and its clinical development in additional indications. There has been some coverage about the safety of Nuplazid this year, which has weighed on the stock.

The Angle

Subject Matter

  • Healthcare 67.57%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 32.43%

Emotional Reaction






Dimensions/Depth Chart

If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.

Accordingly, you can do the same with others as well.